Cognizant announced its collaboration with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to accelerate the speed and quality of drug development. medicinal therapies.
Leveraging Veeva Development Cloud, Cognizant will help Boehringer Ingelheim unify medicinal development processes and data into a connected technology ecosystem, improving collaboration between clinical, regulatory and quality functions, the statement said.
“Achieving an end-to-end platform to accelerate the development of life-changing therapies has been a complicated goal for many organizations, and we are making that vision a reality,” said Uli Brӧdl, Senior Vice President of global clinical development at Boehringer Ingelheim. “Our collaborations with Cognizant and Veeva allow us to advance this important program that will have a positive impact on the lives of patients. »
Dubbed the “One Medicine Platform,” Boehringer Ingelheim’s connected ecosystem is expected to be one of the largest implementations of Veeva technology globally. By bringing together Boehringer Ingelheim’s clinical, regulatory and quality functions on this unified platform, this holistic approach is expected to increase interoperability and operational efficiency.
Cognizant began Boehringer Ingelheim’s engagement with an analysis of the biopharmaceutical manufacturer’s business and technology, followed by the development of the program roadmap and agile methodology for systems integration. Working with Veeva, Cognizant currently implements services that include program management, system architecture and design, training, data migration, integration, testing, and validation services.
“Using cutting-edge technologies to improve the quality and delivery of new medicines is a necessity for innovative pharmaceutical companies, and Boehringer Ingelheim stands out for its forward-thinking in the further development of One Medicine Platform,“ said said Srini Shankar, global head of Cognizant Life Sciences. “Veeva has been recognized as one of the fastest growing life science technology companies, and Cognizant is a capable systems integrator with the expertise to implement multiple Veeva platforms simultaneously. We are proud to work together to set new precedents in how clinical, regulatory and quality functions come together to accelerate the delivery of lifesaving new therapies.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.